Medtronic rolls out novel CRT-D leads in Europe; UCLA makes Alzheimer's Dx headway;

 @FierceMedDev: Report: Life Tech may have found a buyer after all. Story | Follow @FierceMedDev

 @MarkHFierce: Royalty financing may not be new, but it's novel for the medical device world. More | Follow @MarkHFierce

 @DamianFierce: Boston Scientific is holding back some data on Watchman, and market watchers are a little spooked. Report | Follow @DamianFierce

> With CE mark in hand, Medtronic ($MDT) is kicking off the European launch of its Attain Performa portfolio of quadripolar leads, designed to fit its CRT-D devices. News

> Boston Scientific ($BSX) has launched two new sizes of its Rubicon Support Catheter, designed to treat peripheral artery disease. More

> Researchers at UCLA have discovered a new genetic risk factor for Alzheimer's that could help diagnose the disease years before it takes effect. Release

> GN Otometrics' ICS Impulse, a bedside ECG for the eye, demonstrated that it can accurately distinguish stroke from other causes of dizziness. Article

> The state-funded Kansas Bioscience Authority is investing $375,000 in local devicemaker Novita Therapeutics, a company that produces dialysis and brain aneurysm technologies. Story

> VisionQuest 20/20 has developed a video game that measures visual acuity and depth perception in schoolchildren, helping to diagnose vision problems that often elude traditional eye tests. Report

Biotech News

 @FierceBiotech: Popular yesterday: Theravance: Biotech's big coming-of-age story. Editor's Corner | Follow @FierceBiotech

@JohnCFierce: TauRx adds $10.5M to its unconventional trove of Alzheimer's PhIII cash. News | Follow @JohnCFierce

@RyanMFierce: Engineering issues have stymied the mini DNA sequencer from Oxford Bio. Blogger says the tech chief is angry: Report | Follow @RyanMFierce

> Japan's Ajinomoto pounces on Althea Tech in $175M buyout deal. News

> TauRx adds $10.5M to its trove of unconventional Alzheimer's PhIII cash. Story

> Teva retrenches on troubled MS blockbuster hopeful as partner grabs $43M. More

> Antibiotics outfit Tetraphase offers price range for $75M biotech IPO. Article

Pharma News

@FiercePharma: Longtime Roche chairman Franz Humer is stepping aside. Who's up next? More | Follow @FiercePharma

@EricPFierce: Pfizer building a plant in Saudi Arabia as MENA area becomes of more interest to Big Pharma. Story | Follow @EricPFierce

> Lilly CEO blasts Europe's drug-pricing moves. Story

> Par to pay $45M for off-label Megace marketing. News

Biomarkers News

> Advanced Cell Diagnostics enables cancer immunotherapy biomarker work. Story

> Australian team builds depression blood test around quinolinic acid. More

> Biomarker shines a light on new pathway to target neuroblastoma. Report

> Scripps scientists spot tropical disease marker in urine. Article

> Ignyta, Lieden University team on RA biomarker research. Item

Drug Delivery News

@MichaelGFierce: Yale researchers improve lupus drug with nanogel delivery. More | Follow @MichaelGFierce

> Actium BioSystems puts the heat on cancer with hyperthermic delivery. Report

> Mercator micro-infusion drug delivery catheter snags CE mark. News

> Combo drug, Dx nanomedicine deliver cancer-fighting payload. Article

> West launches intradermal adapter for shallow injections. Item

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.